LEONARD M BLUM Insider Trading
Get free email notifications about insider trading for LEONARD M BLUM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LEONARD M BLUM. LEONARD M BLUM is a Sr. VP, Sales and Mktg in ICOS CORP ($ICOS) and a VP, Sales and Marketing in ICOS CORP ($ICOS) and a See Remarks in EyePoint Pharmaceuticals, Inc. ($PSDV) and a Sr VP, Chief Comm. Officer in Theravance Biopharma, Inc. ($TBPH).
Address: 22021 - 20TH AVENUE SE BOTHELL 98021 WA
Companies in which LEONARD M BLUM is an Insider
EyePoint Pharmaceuticals, Inc.
Trading Symbol: EYPTIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of LEONARD M BLUM: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 16 2018
$EYPT Market Capitalization: $60.15M
$EYPT Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ICOS CORP
Trading Symbol: ICOSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LEONARD M BLUM: Sr. VP, Sales and Mktg, VP, Sales and Marketing
Holdings: 85,829 shares
Latest Transaction: Jan 26 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Trading Symbol: TBPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LEONARD M BLUM: Sr VP, Chief Comm. Officer
Holdings: 182,731 shares
Current Value: $5,591,569
Latest Transaction: Feb 23 2016
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of LEONARD M BLUM
Sentiment: All, EYPT, ICOS, TBPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 16 2018 | PSDV | EyePoint Pharmaceu ... | BLUM LEONARD M | See Remarks | Option Exercise | A | 1.95 | 65,000 | 126,750 | 65,000 | |
May 16 2018 | PSDV | EyePoint Pharmaceu ... | BLUM LEONARD M | See Remarks | Option Exercise | A | 1.95 | 375,000 | 731,250 | 375,000 | |
Feb 23 2016 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 15.65 | 16,101 | 251,981 | 182,731 | 198.8 K to 182.7 K (-8.10 %) |
Aug 24 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 12.98 | 934 | 12,123 | 198,832 | 199.8 K to 198.8 K (-0.47 %) |
Jun 04 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 13.83 | 7,360 | 101,789 | 199,766 | 207.1 K to 199.8 K (-3.55 %) |
May 22 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 14.24 | 673 | 9,584 | 207,126 | 207.8 K to 207.1 K (-0.32 %) |
Feb 24 2015 | TBPH | Theravance Biophar ... | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 19.52 | 674 | 13,156 | 207,799 | 208.5 K to 207.8 K (-0.32 %) |